Spanish Red Biotech Pipeline

MSD

V-937/Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Clinical Study of Intratumoral Administration of V937 in Combination with Pembrolizumab (MK-3475) in Participants with Advanced/Metastatic Solid Tumors
Phase: 2Phase II in Spain, 1Phase I in Spain